← Back to Clinical Trials
Recruiting NCT06307275

NCT06307275 Intermittent Fasting on Body Fat and Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06307275
Status Recruiting
Phase —
Sponsor Loma Linda University
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-03-11
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Fastingnon fasting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2024-03-11 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life.

Eligibility Criteria

Inclusion Criteria: • In good health Exclusion Criteria: • Diabetes or Metabolic Syndrome

Contact & Investigator

Central Contact

Gurinder Bains, PhD

✉ gbains@llu.edu

📞 909-558-4000

Principal Investigator

Gurinder Bains, PhD

PRINCIPAL INVESTIGATOR

Loma Linda University

Frequently Asked Questions

Who can join the NCT06307275 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06307275 currently recruiting?

Yes, NCT06307275 is actively recruiting participants. Contact the research team at gbains@llu.edu for enrollment information.

Where is the NCT06307275 trial being conducted?

This trial is being conducted at Loma Linda, United States.

Who is sponsoring the NCT06307275 clinical trial?

NCT06307275 is sponsored by Loma Linda University. The principal investigator is Gurinder Bains, PhD at Loma Linda University. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology